It has been shown that high levels of Mcl-1 and Bcl-2 mRNA and protein were founded in CLL, which are inversely correlated with in-vitro response to chemotherapeutic agents and with the failure of CLL patients to respond to fludarabine therapy (4). The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.